NEUVOGEN

Neuvogen

Biotechnology, Flintkote Avenue, San Diego, , 92121, California, 11095, United States, 51-200 Employees

neuvogen.com

  • LinkedIn

phone no Phone Number: +16*********

Who is NEUVOGEN

NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated. Our mission is to serve patients wit...

Read More

map
  • 11095 Flintkote Avenue, San Diego, California, 92121, United States Headquarters: 11095 Flintkote Avenue, San Diego, California, 92121, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $5 Million to $10 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 5122

checked-icon Does something look wrong? Fix it. | View contact records from NEUVOGEN

NEUVOGEN Org Chart and Mapping

Employees

Bernadette Ferraro

Vice President, Immunoncology

Keith Pelton

Information Technology Administrator

Bill Entrup

Principal Technology Transfer Consultant

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding NEUVOGEN

Answer: NEUVOGEN's headquarters are located at Flintkote Avenue, San Diego, , 92121, California, 11095, United States

Answer: NEUVOGEN's phone number is +16*********

Answer: NEUVOGEN's official website is https://neuvogen.com

Answer: NEUVOGEN's revenue is $5 Million to $10 Million

Answer: NEUVOGEN's SIC: 5122

Answer: NEUVOGEN has 51-200 employees

Answer: NEUVOGEN is in Biotechnology

Answer: NEUVOGEN contact info: Phone number: +16********* Website: https://neuvogen.com

Answer: NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated. Our mission is to serve patients with cancer by developing transformative therapies to meaningfully extend their lives. NEUVOGENs vision is to revolutionize cancer treatment by harnessing the full power of a patients immune system to eliminate cancer from their body. We have taken a fundamentally different approach to solving cancer. Unlike other early-stage immunoncology companies, we try to solve for multiple issues arising from the complexity of cancer biology. Our approach to solving cancer is based on the concept that in order to fully address the complexity of solid tumor cancer biology, many targets and multiple biologic pathways need to be addressed simultaneously. NEUVOGEN is advancing a broad pipeline of therapeutic whole cell cancer vaccine candidates designed to activate the patients immune system to target and eliminate existing tumors and prevent future metastases. Our research programs focus on therapeutic cancer vaccines to treat a wide range of tumor types across numerous solid tumor indications.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access